Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents
Table 2
Stent and ISR vessel characteristics of the study population.
ISR ()
Non-ISR ()
value
Target vessel
LM
3 (3.0)
2 (2.5)
0.59
LAD
42 (53.2)
40 (50.6)
LCX
12 (15.2)
10 (12.7)
RCA
22 (27.8)
27 (34.2)
Number of stents implanted ()
1.49 ± 0.57
1.58 ± 0.65
0.47
Total stent length (mm)
41.36 ± 18.4
42.46 ± 21.04
0.96
Maximal stent diameter per lesion (mm)
2.97 ± 0.36
3.14 ± 0.39
0.02
ISR Mehran classification, (%)
Type I
42 (53.2)
N/A
N/A
Type II
12 (15.2)
N/A
N/A
Type III
13 (16.5)
N/A
N/A
Type IV
12 (15.2)
N/A
N/A
Values are presented as number (%) or mean value ± standard deviation. LM = left main artery; LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right coronary artery; ISR = in-stent restenosis; N/A = not applicable.
